Equasens Société anonyme Past Earnings Performance
Past criteria checks 5/6
Equasens Société anonyme has been growing earnings at an average annual rate of 15.5%, while the Healthcare Services industry saw earnings growing at 2.2% annually. Revenues have been growing at an average rate of 9.6% per year. Equasens Société anonyme's return on equity is 25%, and it has net margins of 21.7%.
Key information
15.5%
Earnings growth rate
15.4%
EPS growth rate
| Healthcare Services Industry Growth | 21.0% |
| Revenue growth rate | 9.6% |
| Return on equity | 25.0% |
| Net Margin | 21.7% |
| Next Earnings Update | 27 Sep 2024 |
Recent past performance updates
Recent updates
Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns
Apr 03
At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?
Mar 08Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E
Feb 14Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 27Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?
Nov 29These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely
Oct 28A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Sep 27Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Aug 05Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15
Jun 11Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 22Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 08What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?
Apr 04Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends
Feb 13Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 26At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?
Dec 21Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?
Dec 07Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital
Nov 12Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?
Oct 27Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Oct 12When Should You Buy Equasens Société anonyme (EPA:EQS)?
Sep 09With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case
Aug 24Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively
Jul 28Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05
Jun 10Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05
May 27Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
May 22Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean
Apr 25Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?
Feb 23Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today
Feb 09Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?
Jan 25Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital
Jan 06Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt
Nov 14Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?
Oct 30Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
Sep 28Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?
Jul 18Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends
Jun 24Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?
Apr 08Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why
Mar 24Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 03Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)
Feb 09
Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return
Jan 12What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend
Dec 15Are Strong Financial Prospects The Force That Is Driving The Momentum In Pharmagest Interactive SA's EPA:PHA) Stock?
Dec 01Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Equasens Société anonyme makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 223 | 48 | 0 | 0 |
| 31 Mar 23 | 219 | 47 | 0 | 0 |
| 31 Dec 22 | 214 | 46 | 0 | 0 |
| 30 Jun 22 | 203 | 42 | 0 | 0 |
| 31 Mar 22 | 198 | 41 | 0 | 0 |
| 31 Dec 21 | 193 | 39 | 0 | 0 |
| 30 Sep 21 | 190 | 37 | 0 | 0 |
| 30 Jun 21 | 188 | 35 | 0 | 0 |
| 31 Mar 21 | 180 | 33 | 0 | 0 |
| 31 Dec 20 | 172 | 31 | 0 | 0 |
| 30 Sep 20 | 166 | 29 | 0 | 0 |
| 30 Jun 20 | 160 | 27 | 0 | 0 |
| 31 Mar 20 | 159 | 27 | 0 | 0 |
| 31 Dec 19 | 159 | 27 | 0 | 0 |
| 30 Sep 19 | 156 | 27 | 0 | 0 |
| 30 Jun 19 | 153 | 26 | 0 | 0 |
| 31 Mar 19 | 151 | 26 | 0 | 0 |
| 31 Dec 18 | 148 | 25 | 0 | 0 |
| 30 Sep 18 | 144 | 25 | 0 | 0 |
| 30 Jun 18 | 139 | 24 | 0 | 0 |
| 31 Mar 18 | 134 | 24 | 0 | 0 |
| 31 Dec 17 | 130 | 23 | 0 | 0 |
| 30 Sep 17 | 129 | 22 | 0 | 0 |
| 30 Jun 17 | 128 | 21 | 0 | 0 |
| 31 Mar 17 | 128 | 21 | 0 | 0 |
| 31 Dec 16 | 128 | 21 | 0 | 0 |
| 30 Sep 16 | 125 | 20 | 0 | 0 |
| 30 Jun 16 | 121 | 20 | 0 | 0 |
| 31 Mar 16 | 117 | 19 | 0 | 0 |
| 31 Dec 15 | 113 | 19 | 0 | 0 |
| 30 Sep 15 | 113 | 18 | 0 | 0 |
| 30 Jun 15 | 112 | 18 | 0 | 0 |
| 31 Mar 15 | 113 | 17 | 0 | 0 |
| 31 Dec 14 | 115 | 17 | 0 | 0 |
| 30 Sep 14 | 114 | 17 | 0 | 0 |
| 30 Jun 14 | 113 | 16 | 0 | 0 |
| 31 Mar 14 | 113 | 16 | 0 | 0 |
| 31 Dec 13 | 113 | 16 | 0 | 0 |
| 30 Sep 13 | 113 | 15 | 0 | 0 |
| 30 Jun 13 | 113 | 15 | 0 | 0 |
Quality Earnings: EQS has high quality earnings.
Growing Profit Margin: EQS's current net profit margins (21.7%) are higher than last year (20.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EQS's earnings have grown by 15.5% per year over the past 5 years.
Accelerating Growth: EQS's earnings growth over the past year (14.8%) is below its 5-year average (15.5% per year).
Earnings vs Industry: EQS earnings growth over the past year (14.8%) exceeded the Healthcare Services industry 11.7%.
Return on Equity
High ROE: EQS's Return on Equity (25%) is considered high.